Innovation

Alpha-actinin 4 (ACTN4) monoclonal antibody.

University of Pittsburgh
posted on 08/23/2010

Investigators at the University of Pittsburgh have developed a monoclonal antibody to Alpha-actinin 4.

Suggested Uses

  • Research tool

Innovation Details
 

Detailed Description

Alpha-actinin 4 (ACTN4) is a bundling protein thought to anchor actin to various intracellular structures.

Antigen: ACTN4
Clone Name: 93
Isotype:
Immunogen: recombinant protein containing ACTN4 residues 311-911
Applications: Western, immunoprecipitation, immunofluorescent staining
Species reactivity: Human, mouse
Gene/Protein information: Entrez Gene: 81 and UniProtKB: O43707

Available for license as a research tool

File Number: 2017 


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Maria Vanegas at University of Pittsburgh for more information.

Request more info via email request more info
People

Case Manager:

Maria Vanegas Maria Vanegas

Innovations (56)

Download Technology Brief (PDF)


[?]
Followed By

Follow this innovation



No one is following this innovation.

Organization
520

University of Pittsburgh


Communities
Profile
Related Tags

Find more innovations

February 11, 2009

7,868 members 17,196 innovations 152 organizations

Browse

Alfred R Berkeley, Chairman, Pipeline Financial Group, Inc., Former President and Vice Chairman, Nasdaq Stock Market, Inc.

"Our economy is inextricably intertwined with university innovations. Unfortunately, our country’s short-term outlook often interferes with the long-term possibilities of university research and collaborations with industry and entrepreneurs..."  read more...